BD Veritor

Device Becton, Dickinson and Company
Total Payments
$3.7M
Transactions
70
Doctors
1
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2020 $3.7M 68 0
2018 $3,170 1 0
2017 $142.88 1 1

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $3.7M 69 100.0%
Gift $142.88 1 0.0%

Payments by Type

Research
$3.7M
69 transactions
General
$142.88
1 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
Veritor Antigen Assay Becton, Dickinson and Company $3.6M 0
Veritor Acute Becton, Dickinson and Company $168,962 0
Veritor Pediatric Population Becton, Dickinson and Company $17,511 0
Viper LT HPV Longitudinal Becton, Dickinson and Company $3,170 0
Veritor LTC population Becton, Dickinson and Company $2,090 0

Top Doctors Receiving Payments for BD Veritor

Doctor Specialty Location Total Records
Unknown Kansas City, MO $3.7M 69
, M.D Pediatrics Nashua, NH $142.88 1

About BD Veritor

BD Veritor is a device associated with $3.7M in payments to 1 healthcare providers, recorded across 70 transactions in the CMS Open Payments database. The primary manufacturer is Becton, Dickinson and Company.

Payment data is available from 2017 to 2020. In 2020, $3.7M was paid across 68 transactions to 0 doctors.

The most common payment nature for BD Veritor is "Unspecified" ($3.7M, 100.0% of total).

BD Veritor is associated with 5 research studies, including "Veritor Antigen Assay" ($3.6M).